At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 23 enrolled
Drug / intervention
Ibuprofen +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of Lidocaine Patch in Acute Musculoskeletal Pain in the Emergency Department: A Prospective Randomized Controlled Study
In Brief
A Phase 3 clinical trial evaluating Ibuprofen and Lidocaine Patch 4% for Acute Musculoskeletal Disease and 6 related conditions. Completed, enrolled 23 participants across 1 site.
Detailed Summary
This study evaluates the addition of a lidocaine patch to ibuprofen in the treatment of acute musculoskeletal pains. Half of the participants will get only ibuprofen for their pain, while other half will receive lidocaine patch plus the ibuprofen. After addition of the pain medications, the participants will be followed for their pain scores and return visits.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Musculoskeletal Disease, Sprains, Sprains and Strains, Injuries, Emergencies, Trauma, Acute Pain
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20192020202120222023202420252026
Enrollment StartJun 2018
First PostedJun 2018
Primary CompletionDec 2020
Study CompletionJan 2021
TodayJul 2026
First PostedJun 28, 2018
Enrollment StartJun 23, 2018
Primary CompletionDec 30, 2020
Study CompletionJan 30, 2021
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 8.0 years ago
Interventions
Ibuprofendrug
Ibuprofen tablet
Lidocaine Patch 4%drug
Lidocaine patch